Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Bromocriptine to Reduce Body Temperature in Febrile Critically-ill Adults With Acute Neurologic Disease: an Open-label, Blinded Endpoint, Randomized Controlled Trial

NCT03496545 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03496545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03496545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Bromocriptine to Reduce Body Temperature in Febrile Critically-ill Adults With Acute Neurologic Disease: an Open-label, Blinded Endpoint, Randomized Controlled Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2018
Completion date
November 2, 2019
Enrollment
47 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fever, intracerebral hemorrhage, ischemic stroke, subarachnoid hemorrhage, subdural hematoma, traumatic brain injury